Compare EPM & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPM | CBUS |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Agricultural Chemicals |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.2M | 69.9M |
| IPO Year | 1996 | 2017 |
| Metric | EPM | CBUS |
|---|---|---|
| Price | $3.36 | $2.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.93 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 564.0K | 191.9K |
| Earning Date | 02-10-2026 | 11-13-2025 |
| Dividend Yield | ★ 13.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $85,232,000.00 | $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.22 | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.43 | $1.09 |
| 52 Week High | $5.70 | $3.40 |
| Indicator | EPM | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 28.46 | 74.51 |
| Support Level | $3.54 | $1.59 |
| Resistance Level | $3.71 | $1.80 |
| Average True Range (ATR) | 0.12 | 0.16 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 1.98 | 93.55 |
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.